Iterum Therapeutics Plc (ITRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,820 | -28,621 | -16,100 | -103,130 | -79,489 |
| Depreciation Amortization | 7,940 | 4,798 | 1,653 | 514 | 356 |
| Accounts payable and accrued liabilities | -12,879 | -13,240 | -9,185 | 11,446 | 10,487 |
| Other Working Capital | -20,287 | -21,538 | -15,022 | 17,899 | 18,734 |
| Other Operating Activity | 20,549 | 17,521 | 11,263 | -8,651 | -8,957 |
| Operating Cash Flow | $-45,497 | $-41,080 | $-27,391 | $-81,922 | $-58,869 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 40,125 | 40,125 |
| PPE Investments | -11 | -2 | N/A | -24 | -22 |
| Investing Cash Flow | $-11 | $-2 | $N/A | $40,101 | $40,103 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 744 | 744 | N/A | N/A | N/A |
| Debt Repayment | -4,655 | -3,103 | -1,552 | -1,034 | N/A |
| Common Stock Issued | 8,560 | 4,328 | N/A | 3,097 | 3,097 |
| Other Financing Activity | 44,699 | 46,612 | 47,423 | 0 | 0 |
| Financing Cash Flow | $49,348 | $48,581 | $45,871 | $2,063 | $3,097 |
| Exchange Rate Effect | -35 | -33 | -24 | -22 | -29 |
| Beginning Cash Position | 4,891 | 4,891 | 4,891 | 44,671 | 44,671 |
| End Cash Position | 8,696 | 12,357 | 23,347 | 4,891 | 28,973 |
| Net Cash Flow | $3,805 | $7,466 | $18,456 | $-39,780 | $-15,698 |
| Free Cash Flow | |||||
| Operating Cash Flow | -45,497 | -41,080 | -27,391 | -81,922 | -58,869 |
| Capital Expenditure | -11 | -2 | N/A | -24 | -22 |
| Free Cash Flow | -45,508 | -41,082 | -27,391 | -81,946 | -58,891 |